Cas no 110505-63-0 (Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1))
Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) Chemical and Physical Properties
Names and Identifiers
-
- Benzoic acid, 4-(chloromethyl)-, sodium salt
- Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1)
-
- Inchi: 1S/C8H7ClO2.Na.H/c9-5-6-1-3-7(4-2-6)8(10)11;;/h1-4H,5H2,(H,10,11);;
- InChI Key: RCDWAMAWPQDCRZ-UHFFFAOYSA-N
- SMILES: C(C1C=CC(CCl)=CC=1)(=O)O.[NaH]
Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-7847555-0.05g |
sodium 4-(chloromethyl)benzoate |
110505-63-0 | 95.0% | 0.05g |
$101.0 | 2025-02-22 |
Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) Related Literature
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
Additional information on Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1)
Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) and its Applications in Modern Chemical Biology
Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) (CAS No. 110505-63-0) is a versatile compound that has garnered significant attention in the field of chemical biology due to its unique structural and functional properties. This compound, characterized by a benzoic acid core substituted with a chloromethyl group at the 4-position and counterbalanced with a sodium salt form, exhibits a range of biochemical activities that make it invaluable in both academic research and industrial applications.
The structural motif of Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) combines the aromatic stability of benzoic acid with the reactivity of the chloromethyl group. This dual functionality allows the compound to serve as a valuable intermediate in the synthesis of various bioactive molecules. The presence of the sodium salt form enhances its solubility in aqueous solutions, making it particularly useful in biochemical assays and drug development processes.
In recent years, Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) has been extensively studied for its potential applications in medicinal chemistry. The chloromethyl group is known to participate in nucleophilic addition reactions, which can be exploited to construct complex molecular architectures. This reactivity has been leveraged in the development of novel therapeutic agents targeting various diseases.
One of the most promising areas of research involving Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) is its role as a precursor in the synthesis of small-molecule inhibitors. These inhibitors have shown efficacy in modulating key biological pathways associated with cancer, inflammation, and neurodegenerative disorders. For instance, studies have demonstrated that derivatives of this compound can inhibit enzymes such as kinases and phosphatases, which are aberrantly expressed in many diseases.
The pharmacological potential of Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) has also been explored in the context of antimicrobial agents. The benzoic acid moiety is known to possess antimicrobial properties, while the chloromethyl group can be further functionalized to enhance binding affinity to bacterial enzymes. This combination has led to the discovery of novel compounds with improved antimicrobial activity against resistant strains.
Moreover, Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) has found applications in materials science and nanotechnology. Its ability to form coordination complexes with metal ions makes it useful in designing metal-organic frameworks (MOFs) and other functional materials. These materials have potential applications in catalysis, gas storage, and sensing technologies.
The synthesis of Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) typically involves the reaction of 4-chlorobenzaldehyde with sodium hydroxide followed by methylation and subsequent salt formation. This synthetic route highlights the compound's accessibility and scalability for industrial production. Advances in synthetic methodologies have further optimized these processes, ensuring high yields and purity levels suitable for sensitive biological applications.
In conclusion, Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1) represents a fascinating compound with broad utility across multiple scientific disciplines. Its unique structural features and reactivity make it an indispensable tool for researchers investigating new therapeutic strategies and advanced materials. As our understanding of its biochemical properties continues to evolve, so too will its applications in addressing some of the most pressing challenges in modern science and medicine.
110505-63-0 (Benzoic acid, 4-(chloromethyl)-, sodium salt (1:1)) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)